VRX | HARD TO SEE A WAY OUT FROM HERE

10/22/15 11:56AM EDT

VRX | HARD TO SEE A WAY OUT FROM HERE - VRX CDS

OVERVIEW

The title of our short presentation on VRX back in July 2014 was "Something New Under The Sun?".  It seems like a good title in retrospect. 

Click Here for the original deck

its hard to see a way out from here...

  • Claim edits likely go to "deny all" for anything come out of a pharmacy named in the media or associate with VRX
  • Extreme RX price inflation practices put a fast halt to prescription growth
  • Regulatory scrutiny does not end quickly
  • Yields are blowing out, debt and equity capital raises look out of reach, limiting buy-back potential and end to a debt-fueled acquisition binge and the "new pharmaceutical" model.
  • How quickly does anyone really think VRX can restart the R&D engines?

VRX | HARD TO SEE A WAY OUT FROM HERE - VRX LEV LOAN

VRX | HARD TO SEE A WAY OUT FROM HERE - VRX 7

VRX | HARD TO SEE A WAY OUT FROM HERE - VRX 558

Please call or e-mail with any questions.

Thomas Tobin
Managing Director 

@HedgeyeHC  

Andrew Freedman

Analyst

@HedgeyeHIT 

© 2024 Hedgeye Risk Management, LLC. The information contained herein is the property of Hedgeye, which reserves all rights thereto. Redistribution of any part of this information is prohibited without the express written consent of Hedgeye. Hedgeye is not responsible for any errors in or omissions to this information, or for any consequences that may result from the use of this information.